ABSTRACT
In 1987, the California Occupational Health Program (COHP), California Department of Health Services (CDHS), conducted a study of health care workers’ (HCW) exposures to the antiviral drug ribavirin. HCWs at several hospitals had raised concern about the safety of ribavirin, based on three factors: the drug is a potent animal teratogen; it is usually administered as a respirable aerosol, with the excess discharged into patient care areas; and the staff in those areas o en include pregnant women.
